Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History for NCT04878432, showing an updated Study Status. This reflects a recent change in the trial's status recorded by ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2025-11-03T01:05:12.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Updates date-related references: adds 2025-10-16 and a '23 2025-10-08 Study Status References' entry, and removes 2025-07-31.
    Difference
    1%
    Check dated 2025-10-19T16:21:07.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Significant: new government funding and operating-status notice plus a version upgrade to v3.2.0. Removed: old version tag v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T09:08:31.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now lists revision v3.1.0 as the current version, replacing the previous v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-28T03:05:39.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2, indicating a new release; the Back to Top link was removed. No other core content changes detected.
    Difference
    0.6%
    Check dated 2025-09-13T16:51:05.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.6%
    Check dated 2025-09-06T14:07:57.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.